Skip to main content
. Author manuscript; available in PMC: 2018 Mar 29.
Published in final edited form as: N Engl J Med. 2018 Mar 29;378(13):1257–1258. doi: 10.1056/NEJMc1705208

Table. Detection rate of Bordetella pertussis in women who participated in a randomized, double-blind, placebo-controlled trial of trivalent inactivated influenza vaccine.

95%CI: 95% confidence interval; PCR: polymerase chain reaction.

Archived DNA samples independently of clinical presentation were tested by real-time PCR for the presence of the multicopy pertussis insertion sequence (IS) IS4814; if IS481 cycle threshold values were <40, total nucleic acids were extracted from the corresponding achieved respiratory specimen using a NucliSENS easyMAG (bioMerieux) platform and re-tested for IS481 and in a duplex reaction for hIS1001 and pIS1001, and in a singleplex reaction for the pertussis toxin subunit S1 (ptxS1). Primers and probes used, and PCR results interpretation have been described4.

Influenza vaccine N=1062a Placebo N=1054a Risk-Ratio (95%CI) P value
Participants with at least one specimen collected, no (%)b 675 (63.6) 686 (65.1) 1.0 (0.9, 1.0) 0.46
Participants with at least one specimen tested by PCR for pertussis, no (%)b 635 (59.8) 652 (61.9) 1.0 (0.9, 1.0) 0.33
Respiratory specimens collected 1713 1870 - -
Respiratory specimens tested by PCR for pertussis, no (%)c 1494 (87.2) 1631 (87.2) 1.0 (0.9, 1.0) 0.99
Pertussis PCR-positive cases, no (%)d 11 (1.0)f 26 (2.5)g 0.4 (0.2, 0.8) 0.012
Pertussis PCR-indeterminate cases, no (%)e 10 (0.9) 16 (1.5) 0.6 (0.3, 1.4) 0.23
Overall pertussis cases, no (%) 21 (2.0) 42 (4.0) 0.5 (0.2, 0.7) 0.007
a

Participants were followed-up by weekly active surveillance for any respiratory illness from the time of enrolment through pregnancy to 24- weeks post-partum. Pharyngeal specimens were collected by study staff at the time of respiratory illness visits to the study clinic.

b

Percentage calculated from total participants enrolled. Respiratory specimens only collected in participants presenting with a respiratory illness.

c

Percentage calculated from total specimens collected.

d

PCR reaction with cycle threshold values for the IS481 gene <35 or ≤35-<40 plus positive for the ptxS1 gene.

e

PCR reaction with cycle threshold values for the IS481 gene ≤35-<40 and negative for the ptxS1 gene.

f

One specimen also tested positive for influenza A/H1N1.

g

Two specimens also tested positive for influenza A/H3N2. One participant tested pertussis PCR-positive in two different specimens collected 22 days apart, only the first episode was included.